161 related articles for article (PubMed ID: 2898167)
1. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
[TBL] [Abstract][Full Text] [Related]
2. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
3. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
[TBL] [Abstract][Full Text] [Related]
4. Effects of 800 mg cimetidine once daily on gastric acid secretion.
Dammann HG; Walter TA; Mueller P; Simon B
Scand J Gastroenterol Suppl; 1986; 121():25-9. PubMed ID: 3532295
[TBL] [Abstract][Full Text] [Related]
5. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily.
Howden CW; Tsai HH; Reid JL
Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
9. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
10. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
11. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
[TBL] [Abstract][Full Text] [Related]
12. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A
Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
[TBL] [Abstract][Full Text] [Related]
13. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
15. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Kaufmann D; Mappes A; Heim J; Röhmel J
Aliment Pharmacol Ther; 1987 Jun; 1(3):217-23. PubMed ID: 2979224
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.
Savarino V; Mela GS; Scalabrini P; Fera G; Zentilin P; Sumberaz A; Celle G
Eur J Clin Pharmacol; 1988; 35(2):203-7. PubMed ID: 3191940
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
McCullough AJ
Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
[TBL] [Abstract][Full Text] [Related]
19. Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.
Bauerfeind P; Cilluffo T; Emde C; Fimmel C; Kohler W; Gasser T; Blum AL
Digestion; 1987; 37(4):217-22. PubMed ID: 2890546
[TBL] [Abstract][Full Text] [Related]
20. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]